Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

EU grants conditional approval to Roche’s lymphoma drug Polivy

Drug demonstrated a 40% complete response rate in trial

- PMLiVE

New hires at bluebird bio, BioNTech and Provention Bio

The latest movers in pharma

Blood will out

Think carefully about the DNA you’re acquiring

- PMLiVE

IGNIFI expands healthcare team with two new hires

Craig Lambert and Rebecca Dargue join the team

- PMLiVE

My Journey into Medical Communications #LucidLife

In NetworkPharma's latest career guide for wannabe account managers, our very own Aveen Hamid discusses her journey into medical communications and the opportunity to work on programmes that transform patients’...

Lucid Group Communications Limited

- PMLiVE

Novartis gets EU approval for multiple sclerosis therapy Mayzent

Offers subgroup of patients an important new treatment option

- PMLiVE

J&J wins another label expansion for Darzalex in Europe

Multiple myeloma treatment indicated for early use

- PMLiVE

Immuno-oncology, personalised medicine continues to drive pharma sector

New GlobalData survey identifies key trends impacting the industry

OPEN Health expands offering with the launch of a new Learning & Development specialist team

Enhanced expertise to deliver impactful internal training programmes for healthcare clients

OPEN Health

Spotlight interview: 15 minutes on healthcare communications in gene therapy

Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy

OPEN Health

- PMLiVE

The changing nature of approvals – what does the future hold?

The 2019 CMR International Pharmaceutical R&D Factbook

- PMLiVE

W2O acquires advertising and medical education agency 21GRAMS

Acquisition adds 150 experts to the W2O team

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links